COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,399 Articles (22,816 medRxiv, 8,583 bioRxiv)

Most recent first Previous |  Page 1212: Articles 12111-12120  | Next

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Earnest, R., Uddin, R., Matluk, N., Renzette, N., Siddle, K. J., Loreth, C., Adams, G., Tomkins-Tinch, C., Petrone, M. E., Rothman, J. E., Breban, M. I., Koch, R. T., Billig, K., Fauver, J. R., Vogels, C. B. F., Turbett, S., Bilguvar, K., De Kumar, B., Landry, M. L., Peaper, D. R., Kelly, K., Omerza, G., Grieser, H., Meak, S., Martha, J., Dewey, H. H., Kales, S., Berenzy, D., Carpenter-Azevedo, K., King, E., Huard, R. C., Smole, S. C., Brown, C. M., Fink, T., Lang, A. S., Gallagher, G. R., Sabeti, P. C., Gabriel, S., MacInnis, B. L., New England Variant Investigation Team, , Tewhey, R., Adams, M. D., Park, D. J., Lemieux, J. E., Grubaugh, N. D.
10.1101/2021.10.06.21264641 — Posted: 2021-10-07 Discussion: Onsite
Characterizing the effective reproduction number during the COVID-19 epidemic: Insights from Qatar experience
Bsat, R., Chemaitelly, H., Coyle, P., Tang, P., Hasan, M. R., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Nasrallah, G. A., Benslimane, F., Al Khatib, H. A., YASSINE, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J., Ayoub, H. H.
10.1101/2021.10.07.21264599 — Posted: 2021-10-07
Comparison of MIS-C Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine related Myocarditis in Children
Patel, T., Kelleman, M., West, Z., Peter, A., Dove, M., Butto, A., Oster, M.
10.1101/2021.10.05.21264581 — Posted: 2021-10-07 Discussion: Onsite
Serum but not mucosal antibody responses are predicted by pre-existing SARS-CoV-2 spike cross-reactive CD4+ T cells following BNT162b2 vaccination in the elderly
Meyer-Arndt, L., Schwarz, T., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Guercan, K., Uyar-Aydin, Z., Mueller, M. A., Drosten, C., Paul, F., Sander, L. E., Demuth, I., Lauster, R., Giesecke-Thiel, C., Braun, J., Corman, V. M., Thiel, A.
10.1101/2021.10.05.21264545 — Posted: 2021-10-07
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naive and previously infected individuals
Al-Sadeq, D., Shurrab, F., Ismail, A., Amanullah, F. H., Thomas, S., Aldewik, N., Yassine, H. M., Abdul Rahim, H., Abu-Raddad, L. J., Nasrallah, G.
10.1101/2021.10.05.21264550 — Posted: 2021-10-07 Discussion: Onsite
An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh
Kawser, Z., Hossain, M., Suliman, S., Lockman, S., Gitaka, J., Bandawe, G., Rahmat, R., Afrad, M. H., Rahman, M. Z., Hasan, I., Siddik, A. B., Miller, G., Walt, D. R., Ivers, L. C., LaRocque, R. C., Harris, J. B., Qadri, F.
10.1101/2021.10.05.21264551 — Posted: 2021-10-07
Is the infection of the SARS-CoV-2 Delta variant associated with the outcomes of COVID-19 patients?
Gunadi, , Hakim, M. S., Wibawa, H., Marcellus, , Setiawaty, V., Slamet, , Trisnawati, I., Supriyati, E., Khair, R. E., Iskandar, K., Afiahayati, , Siswanto, , Irene, , Anggorowati, N., Daniwijaya, E. W., Nugrahaningsih, D. A. A., Puspadewi, Y., Puspitarani, D. A., Tania, I., Vujira, K. A., Ardlyamustaqim, M. B., Gabriela, G. C., Eryvinka, L. S., Nirmala, B. C., Geometri, E. T., Darutama, A. A., Kuswandani, A. A., Lestari, , Irianingsih, S. H., Khoiriyah, S., Lestari, I., Ananda, N. R., Arguni, E., Nuryastuti, T., Wibawa, T., Yogyakarta-Central Java COVID-19 study group
10.1101/2021.10.05.21262783 — Posted: 2021-10-07 Discussion: Onsite
Postvaccination SARS-CoV-2 infection among healthcare workers: A Systematic Review and meta-analysis
Chandan, S., Khan, S. R., Deliwala, S., Mohan, B. P., Ramai, D., C. Chandan, O., Facciorusso, A.
10.1101/2021.10.04.21264542 — Posted: 2021-10-07 Discussion: Onsite
Rotational worker vaccination provides indirect protection to vulnerable groups in regions with low COVID-19 prevalence
Martignoni, M. M., Rahman, P., Hurford, A.
10.1101/2021.10.05.21264557 — Posted: 2021-10-07
Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination
van den Hoogen, L. L., Smits, G., van Hagen, C. C., Wong, D., Vos, E. R., van Boven, M., de Melker, H. E., van Vliet, J., Kuijer, M., Woudstra, L., Wijmenga-Monsuur, A. J., Geurts van Kessel, C. H., Stoof, S. P., Reukers, D., Wijsman, L. A., Meijer, A., Reusken, C. B., Rots, N. Y., van der Klis, F. R., van Binnendijk, R. S., den Hartog, G.
10.1101/2021.10.05.21264555 — Posted: 2021-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).